Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay

Catherine Alix-Panabières, Klaus Pantel

Open source

DOI
10.1586/14737159.2015.1091729
Published
2015-09-21
Container
Expert Review of Molecular Diagnostics
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1586/14737159.2015.1091729,
  title = {Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay},
  author = {Catherine Alix-Panabières and Klaus Pantel},
  year = {2015},
  journal = {Expert Review of Molecular Diagnostics},
  doi = {10.1586/14737159.2015.1091729},
  url = {https://doi.org/10.1586/14737159.2015.1091729}
}

RIS

TY  - JOUR
TI  - Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay
AU  - Catherine Alix-Panabières
AU  - Klaus Pantel
PY  - 2015
JO  - Expert Review of Molecular Diagnostics
DO  - 10.1586/14737159.2015.1091729
UR  - https://doi.org/10.1586/14737159.2015.1091729
ER  - 

APA

Alix-Panabières, C., & Pantel, K. (2015). Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay. Expert Review of Molecular Diagnostics. https://doi.org/10.1586/14737159.2015.1091729

Source records